BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7995709)

  • 1. Research impact assessment. Principles and applications to proposed, ongoing, and completed projects.
    Kostoff RN
    Invest Radiol; 1994 Sep; 29(9):864-9. PubMed ID: 7995709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the use of citation analysis in research evaluation.
    Moed HF
    Arch Immunol Ther Exp (Warsz); 2009; 57(1):13-8. PubMed ID: 19219533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific peer review to inform regulatory decision making: leadership responsibilities and cautions.
    Patton DE; Olin SS
    Risk Anal; 2006 Feb; 26(1):5-16. PubMed ID: 16492173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A curbstone consult to applicants for National Institute of Mental Health grant support.
    Rush AJ; Gullion CM; Prien RF
    Psychopharmacol Bull; 1996; 32(3):311-20. PubMed ID: 8961773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Result-based financing of medical research].
    Johannessen A; Erik Gilhus N
    Tidsskr Nor Laegeforen; 2009 Mar; 129(7):638-41. PubMed ID: 19337335
    [No Abstract]   [Full Text] [Related]  

  • 6. The positive and negative impacts, and dangers of the impact factor.
    Scully C
    Community Dent Health; 2007 Sep; 24(3):130-4. PubMed ID: 17958071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the impact factor.
    Manske PR
    J Hand Surg Am; 2004 Nov; 29(6):983-6. PubMed ID: 15576205
    [No Abstract]   [Full Text] [Related]  

  • 9. Little evidence to support the use of editorial peer review to ensure quality of published research.
    Richards D
    Evid Based Dent; 2007; 8(3):88-9. PubMed ID: 17891131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use and misuse of journal metrics and other citation indicators.
    Pendlebury DA
    Arch Immunol Ther Exp (Warsz); 2009; 57(1):1-11. PubMed ID: 19219526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is submitted and what gets accepted in Indian Pediatrics: analysis of submissions, review process, decision making, and criteria for rejection.
    Gupta P; Kaur G; Sharma B; Shah D; Choudhury P
    Indian Pediatr; 2006 Jun; 43(6):479-89. PubMed ID: 16820657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical research. Canceling grants, VA research chief shakes the system.
    Couzin J
    Science; 2003 Apr; 300(5619):574-5. PubMed ID: 12714722
    [No Abstract]   [Full Text] [Related]  

  • 15. The top-ten in journal impact factor manipulation.
    Falagas ME; Alexiou VG
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):223-6. PubMed ID: 18661263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peering at peer review revealed high degree of chance associated with funding of grant applications.
    Mayo NE; Brophy J; Goldberg MS; Klein MB; Miller S; Platt RW; Ritchie J
    J Clin Epidemiol; 2006 Aug; 59(8):842-8. PubMed ID: 16828678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research barometer: how is research activity monitored and how is it compared?].
    Djurhuus JC
    Ugeskr Laeger; 2003 Jan; 165(4):322-6. PubMed ID: 12599793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of citation indicators to identify and support high-quality research in Poland.
    Pilc A
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):381-4. PubMed ID: 19043671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the transition to critical pathways--a community behavioral health center's approach.
    Barnette JE; Clendenen F
    Best Pract Benchmarking Healthc; 1996; 1(3):147-56. PubMed ID: 9192562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does impact factor depend upon?
    Roussakis AG; Stamatelopoulos A; Balaka C
    J BUON; 2007; 12(3):415-8. PubMed ID: 17918300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.